K. Suzuki

Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations.

T. Kohno, H. Asamura, K. Shiraishi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumors.

K. Kiyokane, K. Suzuki, S. Sakatani, 2000, Journal of dermatological science.

Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.

S. Tsujitani, N. Kaibara, K. Suzuki, 2000, Anticancer research.

Prognostic significance of reverse transcriptase‐polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma

N. Kaibara, K. Suzuki, M. Makino, 2000, Cancer.

p53 gene mutations in squamous cell carcinoma occurring in scars: comparison with p53 protein immunoreactivity.

K. Kiyokane, H. Kusakabe, K. Suzuki, 1998, The American Journal of dermatopathology.

Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.

N. Hayashi, T. Kamada, Masato Yamamoto, 1996, Cancer research.

Expression of MAGE genes and survival in patients with hepatocellular carcinoma.

S. Tsujitani, Y. Yamaguchi, N. Kaibara, 1999, International journal of oncology.